Vital Images booms
Medical software developer Vital Images achieved a 59% increase in second quarter 2003 revenues and triple the net income of the year-ago quarter. Revenues in Q2 rose to $7.5 million from $4.9 million. Core revenue components-software license fees and
Medical software developer Vital Images achieved a 59% increase in second quarter 2003 revenues and triple the net income of the year-ago quarter. Revenues in Q2 rose to $7.5 million from $4.9 million. Core revenue components-software license fees and maintenance and services-jumped to $6.7 million from $4.2 million. For the second quarter of 2003, the company reported net income of $666,000. Sales to Toshiba accounted for 35% of the company's second quarter revenue, or $2.6 million, compared with $1.4 million in the previous period. Company executives have boosted their 2003 guidance to predict between 45% and 50% growth in core revenue components, with earnings of $2.7 million to $3.1 million. They anticipate positive cash flow for the year.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
